Synergies of radiomics and transcriptomics in lung cancer diagnosis: a pilot studySynergies of radiomics and transcriptomics in lung cancer diagnosis: a pilot study Peer-Reviewed Journal Publication Δημοσίευση σε Περιοδικό με Κριτές 2025-06-042023enRadiotranscriptomics is an emerging field that aims to investigate the relationships between the radiomic features extracted from medical images and gene expression profiles that contribute in the diagnosis, treatment planning, and prognosis of cancer. This study proposes a methodological framework for the investigation of these associations with application on non-small-cell lung cancer (NSCLC). Six publicly available NSCLC datasets with transcriptomics data were used to derive and validate a transcriptomic signature for its ability to differentiate between cancer and non-malignant lung tissue. A publicly available dataset of 24 NSCLC-diagnosed patients, with both transcriptomic and imaging data, was used for the joint radiotranscriptomic analysis. For each patient, 749 Computed Tomography (CT) radiomic features were extracted and the corresponding transcriptomics data were provided through DNA microarrays. The radiomic features were clustered using the iterative K-means algorithm resulting in 77 homogeneous clusters, represented by meta-radiomic features. The most significant differentially expressed genes (DEGs) were selected by performing Significance Analysis of Microarrays (SAM) and 2-fold change. The interactions among the CT imaging features and the selected DEGs were investigated using SAM and a Spearman rank correlation test with a False Discovery Rate (FDR) of 5%, leading to the extraction of 73 DEGs significantly correlated with radiomic features. These genes were used to produce predictive models of the meta-radiomics features, defined as p-metaomics features, by performing Lasso regression. Of the 77 meta-radiomic features, 51 can be modeled in terms of the transcriptomic signature. These significant radiotranscriptomics relationships form a reliable basis to biologically justify the radiomics features extracted from anatomic imaging modalities. Thus, the biological value of these radiomic features was justified via enrichment analysis on their transcriptomics-based regression models, revealing closely associated biological processes and pathways. Overall, the proposed methodological framework provides joint radiotranscriptomics markers and models to support the connection and complementarities between the transcriptome and the phenotype in cancer, as demonstrated in the case of NSCLC.http://creativecommons.org/licenses/by/4.0/Diagnostics134Dovrou_et_al_Diagnostics_13(4)_2023.pdfChania [Greece]Library of TUC2025-06-04application/pdf3.5 MBfree Dovrou Aikaterini Δοβρου Αικατερινη Bei Aikaterini Μπεη Αικατερινη Sfakianakis Stylianos Σφακιανακης Στυλιανος Marias Kostas Papanikolaou Nikolaos Zervakis Michail Ζερβακης Μιχαηλ MDPI Lung cancer Radiomics Transcriptomics Radiotranscriptomics Diagnosis Statistical analysis Machine learning Enrichment analysis